These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5311472)

  • 21. [Catapresan--a new hypotensive agent].
    Tarkowska A
    Pol Tyg Lek; 1969 Jun; 24(24):934-6. PubMed ID: 4896410
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypotensive treatment with an imidazoline derivative].
    Björk-von Bahr S
    Lakartidningen; 1969 Sep; 66(37):3701-4. PubMed ID: 5378942
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S; Malhotra P; Kumari S; Varma S
    J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical studies on differential therapy of hypertension with dichlorophenylaminoimidazoline hydrochloride (Haemiton)].
    Seifert A; Hafemeister G; Kirchner D; Wöstenberg D; Tiedcke H; Ullmann W
    Dtsch Gesundheitsw; 1970 Dec; 25(50):2369-74. PubMed ID: 5509665
    [No Abstract]   [Full Text] [Related]  

  • 25. Moxonidine for hypertension.
    Drug Ther Bull; 1997 May; 35(5):33-6. PubMed ID: 9282418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Our first experiences with the new hypotensive drug Catapresan].
    Grujić M; Robović Z; Perinović M; Rizvanbegović B; Sarić V; Vasiljević M
    Med Arh; 1968; 22(3):75-80. PubMed ID: 5191771
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antihypertensive effect of an imidazole derivative in a group of elderly patients].
    Piliego N; Marinazzo A; De Donno G; Pezzuto A
    Clin Ter; 1970 Nov; 55(3):219-25. PubMed ID: 5516886
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical studies on the antihypertensive effect of Catapresan].
    Kreuziger H; Brehm H
    Med Welt; 1968 Apr; 14():905-7. PubMed ID: 5718198
    [No Abstract]   [Full Text] [Related]  

  • 29. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 30. [Imidazoline receptor agonists in the practical treatment of hypertension].
    Ol'binskaia LI; Bochenkov IuV; Alekseeva IL
    Ter Arkh; 1998; 70(2):86-8. PubMed ID: 9551585
    [No Abstract]   [Full Text] [Related]  

  • 31. Tiamenidine, a centrally acting antihypertensive drug in essential hypertension [proceedings].
    Zamboulis C; Hossmann V; Dollery CT; Eckert H
    Br J Clin Pharmacol; 1979 Oct; 8(4):390P. PubMed ID: 508528
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of an imidazoline derivative on arterial hypertension with or without associated toxemia].
    Delgado Urdapilleta J; Castro Carvajal F
    Ginecol Obstet Mex; 1969 Mar; 25(149):253-6. PubMed ID: 5780802
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the anti-hypertensive effectiveness of Catapresan (ST-155)].
    Ambrosioni E; Corbara F; Perri G
    G Clin Med; 1971 Mar; 52(3):247-65. PubMed ID: 5121120
    [No Abstract]   [Full Text] [Related]  

  • 35. Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide.
    Aigner A; Schmidt U
    Arzneimittelforschung; 1982; 32(8a):976-83. PubMed ID: 6890373
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].
    Kochsiek K; Fritsche H
    Arzneimittelforschung; 1966 Sep; 16(9):1154-60. PubMed ID: 6014733
    [No Abstract]   [Full Text] [Related]  

  • 37. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical study and evaluation of a new guanidine derivative: "Ciclazenine" in the therapy of arterial hypertension].
    Del Guercio R; Valva M; Conti G; Savarese A; Piemontese M
    Rass Int Clin Ter; 1969 May; 49(10):591-604. PubMed ID: 5784806
    [No Abstract]   [Full Text] [Related]  

  • 39. [Arterial hypertension, use of ST 155].
    Califano JE; Lissarrague VM; Ferraris JM; Beilis P
    Prensa Med Argent; 1968 May; 55(13):601-3. PubMed ID: 5669169
    [No Abstract]   [Full Text] [Related]  

  • 40. [1st results with a new antihypertensive agent; or imidazoline hydrochloride (ST 155)].
    Faerchtein I; Francisco Roque A; Kastansky I; Kac LB
    Hospital (Rio J); 1969 May; 75(5):1691-700. PubMed ID: 5306498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.